Peipei Cao Ph.D
	Lecturer Master SUpervisor
	Email: peipei@sxu.edu.cn

---

Education and Work Experience

September 2013 – June 2017: Shanxi Normal University, Biological Sciences, Bachelor's Degree.

September 2017 – June 2020: Nankai University, Physiology, Master's Degree.

September 2020 – June 2024: Nankai University, Biochemistry and Molecular Biology, Ph.D.

July 2024 – Present: Shanxi University, Lecturer

 

Research Interests

Engaged in research related to infection and immunology, with current primary research focuses on:

1. Antimicrobial drug tolerance of      Mycobacterium tuberculosis, pathogenic mechanisms at the cellular level,      and tuberculosis susceptibility;

2. Application of nanomedicine      delivery, bioimaging, and theranostics in tuberculosis.

 

Research Project：

1. Shanxi Provincial Basic Research Program Youth Project, 202403021222028, NPY@ZIF-RG Nanocomposite Drug Delivery System for Synergistic Treatment of Acute Epilepsy, February 2025 – Present, 50,000 RMB, Ongoing, Principal Investigator.

 

Representative Papers：

1.    Peipei Cao, Yue Cheng, Xuebo Yin, Yuhao Li*, et al. Intraocular delivery of ZIF-90-RhB-GW2580 nanoparticles prevents the progression of photoreceptor degeneration. Journal of Nanobiotechnology. 2023; 21(1):44. IF=10.2

2.    Peipei Cao, Hao Zhang, Yuhao Li*, et al. Celecoxib exerts a therapeutic effect against demyelination by improving the immune and inflammatory microenvironments. Journal of Inflammation Research. 2020; 13, 1043-1055. IF=6.92

3.    Zhi Li, Peipei Cao, Yuhao Li, Shuo Wang*, et al. Long-term exposure to 2-amino-3-methylimidazo[4,5-f] quinoline can trigger a potential risk of Parkinson's disease. Journal of Hazardous Materials. 2021; 412, 125230. IF=13.6

4.    Yajia Cheng, Peipei Cao, Yuhao Li, Jianlin Cui*, et al. The adenosine A (2A) receptor antagonist SCH58261 protects photoreceptors by inhibiting microglial activation and the inflammatory response. International Immunopharmacology. 2022; 112:109245. IF=5.6

5.    Hua-Qing Yin, Pei-Pei Cao, Yu-Hao Li, Xue-Bo Yin*, et al. Computed tomography imaging-guided tandem catalysis-enhanced photodynamic therapy with Gold nanoparticle functional covalent organic polymers. ACS Applied Bio Materials. 2020; 3(4):2534-2542. IF=4.7

6.    Hai-Yan Wang, Pei-Pei Cao, Wen-You Li*, Yu-Hao Li*, Yu-Kui Zhang*. Targeted imaging and targeted therapy of breast cancer cells via fluorescent double template-imprinted polymer coated silicon nanoparticles by an epitope approach. Nanoscale. 2019; 11(36): 17018-17030. IF=7.790

7.    Xue-Tao Tian, Pei-Pei Cao, Yu-Hao Li, Xue-Bo Yin*, et al. GSH-activated MRI-guided enhanced photodynamic- and chemo-combination therapy with a MnO₂-coated porphyrin metal organic framework. Chemical Communications. 2019; 55(44):6241-6244. IF=6.222